Followers

Friday, October 28, 2011

Merck has sales third quarter earnings, strong sales of diabetes drug

Merck has sales third quarter earnings, strong sales of diabetes drug Reuters 28] announced third-quarter earnings 28 U.S. pharmaceuticals giant Merck & Co., sales and profits were higher than market expectations. Other vaccines were strong sales of diabetes or cervical cancer, also helped reduce research costs. 1.6 billion to $ 90 million profit ($ 0.55 per share) in the previous year.Merck has sales third quarter earnings, strong sales of diabetes drug

No comments:

Post a Comment

Popular Posts